Related Experiment Video
Updated: Mar 29, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Downregulation of the Long Non-Coding RNA MDL1AS Alters Metabolism, Differentiation, and Radiosensitivity in NTERA2
Adrián Casas-Benito1, Pablo Garrido1, Alfredo Martínez1
1Angiogenesis Group, Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), 26006 Logroño, Spain.
Abstract:
Background/Objectives: Non-coding RNAs provide new chances of targeting multiple oncogenic pathways. Many long non-coding RNAs (lncRNAs) are being characterized as relevant in cancer initiation, progression, and recurrence. Mitochondrial D-loop 1 antisense lncRNA (MDL1AS) is a novel lncRNA that might be important in cancer development, so the aim of this project was to understand its function in differently differentiated cancer cells. Methods: The effects of MDL1AS downregulation on the cellular behavior of NTERA2 and SH-SY5Y cell lines were studied. Results: MDL1AS reduction inhibited oxidative phosphorylation in NTERA2 cells and induced neuritic differentiation in SH-SY5Y cells. This downregulation also produced a strong DNA damage response (DDR) and an increased apoptotic signature by RNAseq analysis, and decreased proliferation in both cell lines. It also decreased radiosensitivity in NTERA2 cells but not in SH-SY5Y. Conclusions: These results suggest that MDL1AS reduction can modulate radiosensitivity, metabolism, and differentiation in a cell type-specific manner. Furthermore, MDL1AS may constitute a predictive biomarker and a molecular target for new therapies.
Insights
Reducing the long non-coding RNA MDL1AS impacts cancer cell radiosensitivity and metabolism. This suggests MDL1AS could be a biomarker for new cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
- MDL1AS is a novel lncRNA with potential involvement in cancer development.
Purpose of the Study:
- To investigate the functional role of MDL1AS in cancer cells with different differentiation states.
- To understand how MDL1AS impacts cellular behavior, metabolism, and response to therapy.
Main Methods:
- Downregulation of MDL1AS in NTERA2 and SH-SY5Y cell lines.
- Analysis of cellular behavior, oxidative phosphorylation, differentiation, proliferation, and DNA damage response.
- RNA sequencing to analyze gene expression changes and apoptotic signatures.
- Assessment of radiosensitivity.
Main Results:
- MDL1AS reduction inhibited oxidative phosphorylation in NTERA2 cells and induced neuritic differentiation in SH-SY5Y cells.
- Downregulation led to a strong DNA damage response and increased apoptosis in both cell lines.
- Proliferation decreased, and radiosensitivity was reduced in NTERA2 cells but not SH-SY5Y cells.
Conclusions:
- MDL1AS downregulation modulates radiosensitivity, metabolism, and differentiation in a cell-type-specific manner.
- MDL1AS may serve as a predictive biomarker for cancer therapies.
- MDL1AS represents a potential molecular target for novel therapeutic strategies.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
